14871849Blank C, Brown I, Peterson AC, Spiotto M, Iwai Y, Honjo T, Gajewski TFCancer researchB7-1 Antigen; Blood Proteins; CD8-Positive T-Lymphocytes; Neoplasms, Experimental; Peptides; Receptors, Antigen, T-CellAnimals; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; B7-H1 Antigen; CTLA-4 Antigen; Interferon-gamma; Membrane Glycoproteins; Mice; Mice, Transgenic; Transduction, Genetic; Up-RegulationPD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells. Cancer Res. 2004 Feb 01; 64(3):1140-5.Cancer Res2004-02-01T00:00:002004PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD001798Chemicals & Drugs841440.941778Blood ProteinsD000943Chemicals & Drugs521410.944612Antigens, DifferentiationD000818Living Beings1457265180.249646AnimalsD000911Chemicals & Drugs33713760.622785Antibodies, MonoclonalD008562Chemicals & Drugs1894280.823162Membrane GlycoproteinsD008822Living Beings37515370.738477Mice, TransgenicAuthorship 243207D007371Chemicals & Drugs1554440.842Interferon-gammaD014161PhysiologyProcedures791530.946729Transduction, GeneticD015854Physiology3257100.800494Up-RegulationD015703Chemicals & Drugs1834570.850227Antigens, CDD009374Disorders1092690.859697Neoplasms, ExperimentalD018122Chemicals & Drugs27750.973203B7-1 AntigenD018414Anatomy1605560.744866CD8-Positive T-Lymphocytes0.247310.247311authors10.2518has subject areaD060890Chemicals & Drugs952500.845952B7-H1 AntigenD051379Living Beings980113130.368427MiceD060908Chemicals & Drugs491350.947137CTLA-4 AntigenD010455Chemicals & Drugs2456390.756144PeptidesD011948Chemicals & Drugs1223710.821927Receptors, Antigen, T-CellPathologyUniversity of ChicagoThomas F.GajewskiThomas F. Gajewski41.78927490000000-87.60125000000000355Gajewski, Thomas F.Professortrue1ProfessorProfessor